Yoshiko Atsuta
Nagakute, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 683 publications
Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.
Journal: Leukemia & lymphoma
Published: August 23, 2026
Clinical Relevance of Transplant Conditioning Intensity Score-Based Refinement of Conditioning Intensity in Cord Blood Transplantation for Myelodysplastic Syndrome.
Journal: Transplantation and cellular therapy
Published: June 27, 2026
Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovir.
Journal: Transplantation and cellular therapy
Published: May 25, 2026
Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.
Journal: Bone marrow transplantation
Published: May 19, 2026
Comparison of post-transplant cyclophosphamide and low-dose anti-thymocyte globulin with dose-dependent effects in mismatched unrelated donor transplantation.
Journal: British journal of haematology
Published: May 14, 2026
Mentorship to support career development among women physicians
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.
Journal: Blood advances
Published: May 05, 2026
Body Mass Index and Outcomes after CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: A Nationwide Registry Study.
Journal: Transplantation and cellular therapy
Published: April 27, 2026
Donor and stem cell source selection in hematopoietic cell transplantation in the Asia-Pacific region: results from the APBMT Activity Survey 2022-2023.
Journal: Blood cell therapy
Published: April 03, 2026
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation.
Journal: Bone marrow transplantation
Published: March 18, 2026
Last Updated: 09/26/2026